date/time interval
- December 13, 2023 - December 12, 2025
Optimizing escalation: Ceftolozane/tazobactam versus treatment with traditional anti-pseudomonal β-lactams for pneumonia or bloodstream infections due to MDR P. aeruginosa (STEWARDS)
Grant
Overview
awarded by
administered by
sponsor award ID
- UP 243556-01
Affiliation
contributor
- Satlin, Michael Principal Investigator (Subaward) 2023 - 2025